Monday, December 23, 2024
HomeTagsAntibody Portfolio

Antibody Portfolio

Ichnos Sciences Enters Licensing Agreement For Ox40 Antagonist Monoclonal Antibody Portfolio With Astria Therapeutics

Ichnos Sciences, a global clinical-stage biotechnology company developing innovative multispecific antibodies for oncology, announced that the company has entered into an exclusive worldwide licensing...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics